FR2736266A1 - Inhibiteur de l'agregation plaquettaire et procede pour preparer celui-ci - Google Patents
Inhibiteur de l'agregation plaquettaire et procede pour preparer celui-ci Download PDFInfo
- Publication number
- FR2736266A1 FR2736266A1 FR9510049A FR9510049A FR2736266A1 FR 2736266 A1 FR2736266 A1 FR 2736266A1 FR 9510049 A FR9510049 A FR 9510049A FR 9510049 A FR9510049 A FR 9510049A FR 2736266 A1 FR2736266 A1 FR 2736266A1
- Authority
- FR
- France
- Prior art keywords
- platelet aggregation
- salmosa
- venom
- salmosin
- korean
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019950019685A KR0142606B1 (ko) | 1995-07-05 | 1995-07-05 | 혈소판 응집 억제 펩타이드 및 그의 제조방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
FR2736266A1 true FR2736266A1 (fr) | 1997-01-10 |
Family
ID=19419881
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR9510049A Pending FR2736266A1 (fr) | 1995-07-05 | 1995-08-24 | Inhibiteur de l'agregation plaquettaire et procede pour preparer celui-ci |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2679780B2 (ko) |
KR (1) | KR0142606B1 (ko) |
FR (1) | FR2736266A1 (ko) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0967276A2 (en) * | 1998-06-23 | 1999-12-29 | Doo-Sik Kim | Anti-tumor agent comprising salmosin |
WO2000018421A1 (en) * | 1998-09-29 | 2000-04-06 | The University Of Southern California | Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
WO2001041791A1 (en) * | 1999-12-10 | 2001-06-14 | The University Of Southern California | Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
US6710030B1 (en) * | 1993-10-22 | 2004-03-23 | University Of Southern California | Contortrostain (CN) and methods for its use in preventing metastasis and other conditions |
US7220724B2 (en) | 1993-10-22 | 2007-05-22 | University Of Southern California | Contortrostatin CN and methods for its use in preventing metastasis and other conditions |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1184313C (zh) | 2000-07-26 | 2005-01-12 | 郑光会 | 衍生自黑眉蝮蛇的新型蛋白以及制备该蛋白的方法 |
KR20020010188A (ko) * | 2000-07-27 | 2002-02-04 | 정광회 | 뱀의 독소로부터 유래된 혈소판 응집억제 단백질 및 그의제조방법 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990008772A1 (en) * | 1989-01-27 | 1990-08-09 | Biogen, Inc. | Processes for producing polypeptide inhibitors of platelet activation and methods, combinations and compositions using them |
EP0382451A2 (en) * | 1989-02-07 | 1990-08-16 | Merck & Co. Inc. | Viper venom Polypeptides and variants |
WO1990015072A1 (en) * | 1989-06-07 | 1990-12-13 | Genentech, Inc. | Platelet aggregation inhibitors and related molecules |
JPH05255395A (ja) * | 1990-10-26 | 1993-10-05 | Takeda Chem Ind Ltd | ポリペプチドおよびその製造法 |
-
1995
- 1995-07-05 KR KR1019950019685A patent/KR0142606B1/ko not_active IP Right Cessation
- 1995-08-24 FR FR9510049A patent/FR2736266A1/fr active Pending
- 1995-09-08 JP JP7230942A patent/JP2679780B2/ja not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990008772A1 (en) * | 1989-01-27 | 1990-08-09 | Biogen, Inc. | Processes for producing polypeptide inhibitors of platelet activation and methods, combinations and compositions using them |
EP0382451A2 (en) * | 1989-02-07 | 1990-08-16 | Merck & Co. Inc. | Viper venom Polypeptides and variants |
WO1990015072A1 (en) * | 1989-06-07 | 1990-12-13 | Genentech, Inc. | Platelet aggregation inhibitors and related molecules |
JPH05255395A (ja) * | 1990-10-26 | 1993-10-05 | Takeda Chem Ind Ltd | ポリペプチドおよびその製造法 |
Non-Patent Citations (4)
Title |
---|
DATABASE GCG-GENESEQ_P Derwent; * |
DATABASE WPI Section Ch Week 9344, Derwent World Patents Index; Class B04, AN 93-348481, XP002048503 * |
M.S. DENNIS ET AL.: "Platelet glycoprotein IIb-IIa protein antagonists from snake venoms: Evidence for a family of platelet-aggregation inhibitors", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 87, April 1989 (1989-04-01), WASHINGTON US, pages 2471 - 2475, XP002048502 * |
T.-F. HUANG ET AL.: "Halysin, an Antiplatelet Arg-Gly-Asp- Containing Snake Venom Peptide, as Fibrinogen Receptor Antagonists", BIOCHEMICAL PHARMACOLOGY, vol. 42, no. 6, 22 August 1991 (1991-08-22), pages 1209 - 1219, XP002048570 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6710030B1 (en) * | 1993-10-22 | 2004-03-23 | University Of Southern California | Contortrostain (CN) and methods for its use in preventing metastasis and other conditions |
US7220724B2 (en) | 1993-10-22 | 2007-05-22 | University Of Southern California | Contortrostatin CN and methods for its use in preventing metastasis and other conditions |
US7718615B2 (en) | 1993-10-22 | 2010-05-18 | University Of Southern California | Contortrostatin (CN) and methods for its use in preventing metastasis and other conditions |
EP0967276A2 (en) * | 1998-06-23 | 1999-12-29 | Doo-Sik Kim | Anti-tumor agent comprising salmosin |
EP0967276A3 (en) * | 1998-06-23 | 2001-04-18 | Doo-Sik Kim | Anti-tumor agent comprising salmosin |
WO2000018421A1 (en) * | 1998-09-29 | 2000-04-06 | The University Of Southern California | Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
WO2001041791A1 (en) * | 1999-12-10 | 2001-06-14 | The University Of Southern California | Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
Also Published As
Publication number | Publication date |
---|---|
KR0142606B1 (ko) | 1998-07-01 |
JPH0920797A (ja) | 1997-01-21 |
JP2679780B2 (ja) | 1997-11-19 |
KR970006318A (ko) | 1997-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hunt et al. | Abnormal human haemoglobins VI. The chemical difference between haemoglobins A and E | |
US5140102A (en) | Pentadecapeptide, guanylin, which stimulates intestinal guanylate cyclase | |
Krahn et al. | Lima bean trypsin inhibitor. Limited proteolysis by trypsin and chymotrypsin | |
US4659694A (en) | Prothymosin alpha | |
JPH04506003A (ja) | 治療剤 | |
JP2980334B2 (ja) | ラットの顎下腺から導出したペプチド及びポリペプチド、対応するポリクローナル及びモノクローナル抗体、対応するハイブリドーマ並びに診断、検出及び治療目的でのこれらの生成物の使用 | |
US4716148A (en) | Prothymosin alpha | |
CA2009390A1 (en) | Viper venom polypeptides and variants | |
Karlsson et al. | A structural feature of human immunoglobulin light chains: two compact domains connected by a small switch region | |
FR2736266A1 (fr) | Inhibiteur de l'agregation plaquettaire et procede pour preparer celui-ci | |
JP2660514B2 (ja) | 抗血液凝固作用を有するポリペプチド | |
JP2004535461A5 (ko) | ||
WO1986001718A1 (fr) | PROCEDE D'OBTENTION DU COMPLEXE FVIII/vWF A USAGE THERAPEUTIQUE ET PRODUITS EN RESULTANT | |
JP3271159B2 (ja) | レニン活性物質 | |
FR2608160A1 (fr) | Nouveaux derives peptidiques et leur application notamment en therapeutique | |
EP0368920B1 (fr) | Lectines fixant le beta-d-galactoside | |
AU634955B2 (en) | Peptides, a process for the preparation thereof, the use thereof for obtaining antibodies, and the use thereof for blocking pai 1 activity in human blood | |
JPH01221396A (ja) | 8因子の精製に使用するペプチド | |
JPH03255095A (ja) | カゼインペプチド | |
JP3276753B2 (ja) | カテプシンl特異的阻害ポリペプチド | |
JPH06220088A (ja) | アンジオテンシンi変換酵素を阻害するトリペプチドおよびその製造法ならびにそれを含む食品 | |
JPH05306296A (ja) | 魚類由来ペプチドとその製法 | |
JPH0570484A (ja) | ペプチドおよびその塩 | |
JPH1080281A (ja) | 新規蛋白質及びその製造方法 | |
JPH0812594A (ja) | アンジオテンシンi変換酵素阻害ペプチド誘導体 |